Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1373 ARTÍCULOS , VIENDO DEL 976 AL 990

Targeted recruitment using cerebrospinal fluid biomarkers: implications for Alzheimer's disease therapeutic trials

Barnes J, Bartlett JW, Fox NC, Schott JM.

J Alzheimers Dis. 2013;34(2):431-7. doi: 10.3233/JAD-121936.

Blood transcriptomic biomarkers of Alzheimer's disease patients treated with EHT 0202

Désiré L, Blondiaux E, Carrière J, Haddad R, Sol O, Fehlbaum-Beurdeley P, Einstein R, Zhou W, Pando MP.

J Alzheimers Dis. 2013;34(2):469-83. doi: 10.3233/JAD-121501.

[A new definition for Alzheimer's disease]

Dubois B.

Bull Acad Natl Med. 2013 Jan;197(1):143-53; discussion 153-6.

Alzheimer's disease dementia guidelines for diagnostic testing: a systematic review

Arevalo-Rodriguez I, Pedraza OL, Rodríguez A, Sánchez E, Gich I, Solà I, Bonfill X, Alonso-Coello P.

Am J Alzheimers Dis Other Demen. 2013 Mar;28(2):111-9. doi: 10.1177/1533317512470209. Epub 2013 Jan 2.

Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection

Risacher SL, Saykin AJ.

Annu Rev Clin Psychol. 2013;9:621-48. doi: 10.1146/annurev-clinpsy-050212-185535. Epub 2013 Jan 7.

Differential processing of amyloid precursor protein in brain and in peripheral blood leukocytes

Delvaux E, Bentley K, Stubbs V, Sabbagh M, Coleman PD.

Neurobiol Aging. 2013 Jun;34(6):1680-6. doi: 10.1016/j.neurobiolaging.2012.12.004. Epub 2013 Jan 5.

Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers

Kosicek M, Hecimovic S.

Int J Mol Sci. 2013 Jan 10;14(1):1310-22. doi: 10.3390/ijms14011310.

Plasma proteomics for the identification of Alzheimer disease

Guo LH, Alexopoulos P, Wagenpfeil S, Kurz A, Perneczky R; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):337-42. doi: 10.1097/WAD.0b013e31827b60d2.

Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol

Mangialasche F, Westman E, Kivipelto M, Muehlboeck JS, Cecchetti R, Baglioni M, Tarducci R, Gobbi G, Floridi P, Soininen H, Kłoszewska I, Tsolaki M, Vellas B, Spenger C, Lovestone S, Wahlund LO, Simmons A, Mecocci P; AddNeuroMed consortium.

J Intern Med. 2013 Jun;273(6):602-21. doi: 10.1111/joim.12037. Epub 2013 Feb 28.

A conceptual framework and ethics analysis for prevention trials of Alzheimer Disease

Peters KR, Lynn Beattie B, Feldman HH, Illes J.

Prog Neurobiol. 2013 Nov;110:114-23. doi: 10.1016/j.pneurobio.2012.12.001. Epub 2013 Jan 21.

State of the science: use of biomarkers and imaging in diagnosis and management of Alzheimer disease

Fraller DB.

J Neurosci Nurs. 2013 Apr;45(2):63-70. doi: 10.1097/JNN.0b013e3182829024.

Elusive Alzheimer's disease: can immune signatures help our understanding of this challenging disease? Part 2: new immune paradigm

Fulop T, Lacombe G, Cunnane S, Le Page A, Dupuis G, Frost EH, Bourgade-Navarro K, Goldeck D, Larbi A, Pawelec G.

Discov Med. 2013 Jan;15(80):33-42.

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

Prestia A, Caroli A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall AE, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB.

Neurology. 2013 Mar 12;80(11):1048-56. doi: 10.1212/WNL.0b013e3182872830. Epub 2013 Feb 6.

Alzheimer disease biomarkers and insights into mild cognitive impairment

Knopman DS.

Neurology. 2013 Mar 12;80(11):978-80. doi: 10.1212/WNL.0b013e31828728ac. Epub 2013 Feb 6.

Cognition and amyloid load in Alzheimer disease imaged with florbetapir F 18(AV-45) positron emission tomography

Rosenberg PB, Wong DF, Edell SL, Ross JS, Joshi AD, Brašić JR, Zhou Y, Raymont V, Kumar A, Ravert HT, Dannals RF, Pontecorvo MJ, Skovronsky DM, Lyketsos CG.

Am J Geriatr Psychiatry. 2013 Mar;21(3):272-8. doi: 10.1016/j.jagp.2012.11.016.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias